title: Non-randomised phase II trials of drug combinations: often meaningless, sometimes misleading. Are there alternative strategies?
authors.forename: M
authors.initials: M
authors.lastname: Van Glabbeke
authors.forename: W
authors.initials: W
authors.lastname: Steward
authors.forename: J P
authors.initials: JP
authors.lastname: Armand
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic / Q000379:methods*; D004938:Esophageal Neoplasms / Q000188:drug therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic / Q000379:methods